Glenmark Pharmaceuticals has informed about submission of media release titled ‘Glenmark Pharmaceuticals receives tentative ANDA approval for Dimethyl Fumarate Delayed?Release Capsules, 120 mg and 240 mg’.
The above information is a part of company’s filings submitted to BSE.